NexGen Research is a clinical research site located in Lima, Ohio, United States 45801.
Crixeo Health Trust Score: 78/100 (FAIR). This profile has not yet been claimed by the site owner.
NexGen Research has participated in 14 clinical trials with 10 currently active.
Therapeutic areas: Primary Prevention of Atherosclerotic Cardiovascular Disease, Painful Lumbosacral Radiculopathy, Resistant Hypertension.
Sponsors: Novartis Pharmaceuticals, Vertex Pharmaceuticals Incorporated, Currax Pharmaceuticals.
Trust Score: 78/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
NexGen Research has a Crixeo Trust Score of 78/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
NexGen Research has 14 clinical trials on record, with 10 currently active. Their work covers Primary Prevention of Atherosclerotic Cardiovascular Disease, Painful Lumbosacral Radiculopathy, Resistant Hypertension.
Yes — NexGen Research holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.